Max J. Turner

761 total citations
22 papers, 617 citations indexed

About

Max J. Turner is a scholar working on Cancer Research, Molecular Biology and Pharmacology. According to data from OpenAlex, Max J. Turner has authored 22 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Max J. Turner's work include Carcinogens and Genotoxicity Assessment (14 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Analytical Chemistry and Chromatography (3 papers). Max J. Turner is often cited by papers focused on Carcinogens and Genotoxicity Assessment (14 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Analytical Chemistry and Chromatography (3 papers). Max J. Turner collaborates with scholars based in United States and Netherlands. Max J. Turner's co-authors include James A. Bond, Bahman Asgharian, Matthew W. Himmelstein, James A. Swenberg, Edward A. Lock, Josef Strasser, Michel Charbonneau, Douglas E. Rickert, Timothy R. Fennell and Susan Sumner and has published in prestigious journals such as Carcinogenesis, Toxicology and Applied Pharmacology and Toxicology.

In The Last Decade

Max J. Turner

22 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max J. Turner United States 14 428 215 211 95 84 22 617
H.-G. Neumann Germany 17 374 0.9× 179 0.8× 279 1.3× 45 0.5× 80 1.0× 43 651
H. Peter Germany 16 340 0.8× 180 0.8× 313 1.5× 66 0.7× 108 1.3× 37 637
H.‐G. Neumann Germany 16 337 0.8× 245 1.1× 203 1.0× 51 0.5× 64 0.8× 31 697
F. Poncelet Belgium 17 534 1.2× 242 1.1× 225 1.1× 88 0.9× 161 1.9× 49 692
Alan L. Mendrala United States 13 510 1.2× 367 1.7× 313 1.5× 179 1.9× 168 2.0× 17 998
István Vincze Hungary 13 315 0.7× 206 1.0× 241 1.1× 45 0.5× 58 0.7× 43 606
N. Fedtke Germany 14 328 0.8× 215 1.0× 202 1.0× 29 0.3× 65 0.8× 17 619
Karen Yeowell-O’Connell United States 14 307 0.7× 206 1.0× 161 0.8× 42 0.4× 30 0.4× 15 496
J.F. Quast United States 17 536 1.3× 356 1.7× 232 1.1× 153 1.6× 130 1.5× 35 933
Mei‐Sie Lee United States 17 405 0.9× 241 1.1× 332 1.6× 81 0.9× 49 0.6× 35 756

Countries citing papers authored by Max J. Turner

Since Specialization
Citations

This map shows the geographic impact of Max J. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max J. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max J. Turner more than expected).

Fields of papers citing papers by Max J. Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max J. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max J. Turner. The network helps show where Max J. Turner may publish in the future.

Co-authorship network of co-authors of Max J. Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Max J. Turner. A scholar is included among the top collaborators of Max J. Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max J. Turner. Max J. Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osterman-Golkar, Siv, et al.. (1998). Epoxybutene–Hemoglobin Adducts in Rats and Mice: Dose Response for Formation and Persistence During and Following Long-Term Low-Level Exposure to Butadiene. Toxicology and Applied Pharmacology. 150(1). 166–173. 17 indexed citations
2.
Callahan, Brian P., Max J. Turner, Richard A. Willis, et al.. (1998). Regulation of human prostate-specific antigen gene expression in transgenic mice: evidence for an enhancer between the PSA and human glandular kallikrein-1 genes.. International Journal of Molecular Medicine. 2(4). 487–96. 7 indexed citations
3.
Asgharian, Bahman, et al.. (1998). Ethylene Oxide Dosimetry in the Mouse. Toxicology and Applied Pharmacology. 148(2). 215–221. 24 indexed citations
4.
Valentine, John L., Peter J. Boogaard, Lisa Sweeney, et al.. (1997). Disposition of butadiene epoxides in Sprague-Dawley rats. Chemico-Biological Interactions. 104(2-3). 103–115. 9 indexed citations
5.
Leavens, Teresa L., Owen R. Moss, Max J. Turner, Derek B. Janszen, & James A. Bond. (1996). Metabolic Interactions of 1,3-Butadiene and Styrene in Male B6C3F1 Mice. Toxicology and Applied Pharmacology. 141(2). 628–636. 4 indexed citations
6.
Boogaard, Peter J., Susan Sumner, Max J. Turner, & James A. Bond. (1996). Hepatic and pulmonary glutathione conjugation of 1,2:3,4-diepoxybutane in human, rat, and mouse in vitro. Toxicology. 113(1-3). 297–299. 8 indexed citations
7.
Himmelstein, Matthew W., Max J. Turner, Bahman Asgharian, & James A. Bond. (1996). Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Toxicology. 113(1-3). 306–309. 29 indexed citations
8.
Kedderis, G.L., Renu Batra, & Max J. Turner. (1995). Conjugation of Acrylonitrile and 2-Cyanoethylene Oxide with Hepatic Glutathione. Toxicology and Applied Pharmacology. 135(1). 9–17. 26 indexed citations
9.
Himmelstein, Matthew W., Max J. Turner, Bahman Asgharian, & James A. Bond. (1994). Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis. 15(8). 1479–1486. 115 indexed citations
10.
Fennell, Timothy R., et al.. (1994). Characterization of phosphodiester adducts produced by the reaction of cyanoethylene oxide with nucleotides. Carcinogenesis. 15(2). 277–283. 19 indexed citations
11.
Turner, Max J., et al.. (1994). Monitoring exposure to acrylonitrile using adducts with N-terminal valine in hemoglobin. Carcinogenesis. 15(12). 2701–2707. 30 indexed citations
12.
Sumner, Susan, et al.. (1993). Characterization of an adduct and its degradation product produced by the reaction of cyanoethylene oxide with deoxythymidine and DNA. Carcinogenesis. 14(7). 1363–1369. 11 indexed citations
13.
Recio, Leslie, Siv Osterman-Golkar, György A. Csanády, et al.. (1992). Determination of mutagenicity in tissues of transgenic mice following exposure to 1,3-butadiene and N-ethyl-N-nitrosourea. Toxicology and Applied Pharmacology. 117(1). 58–64. 38 indexed citations
14.
15.
Fedtke, N., Joyce A. Boucheron, Max J. Turner, & James A. Swenberg. (1990). Vinyl chloride-induced DNA adducts I: Quantitative determination of N2,3-ethenoguanine based on electrophore labeling. Carcinogenesis. 11(8). 1279–1285. 40 indexed citations
16.
Charbonneau, Michel, Josef Strasser, Edward A. Lock, Max J. Turner, & James A. Swenberg. (1989). Involvement of reversible binding to α2u-globulin in 1,4-dichlorobenzene-induced nephrotoxicity. Toxicology and Applied Pharmacology. 99(1). 122–132. 78 indexed citations
17.
Charbonneau, Michel, et al.. (1987). 2,2,4-Trimethylpentane-induced nephrotoxicity. Toxicology and Applied Pharmacology. 91(2). 171–181. 67 indexed citations
18.
Turner, Max J., et al.. (1985). Assessing exposure to dinitrotoluene using a biological monitor.. PubMed. 27(9). 627–38. 7 indexed citations
19.
Turner, Max J., et al.. (1985). Identification and quantification of urinary metabolites of dinitrotoluenes in occupationally exposed humans. Toxicology and Applied Pharmacology. 80(1). 166–174. 20 indexed citations
20.
Chism, John P., Max J. Turner, & Douglas E. Rickert. (1984). The metabolism and excretion of mononitrotoluenes by Fischer 344 rats.. Drug Metabolism and Disposition. 12(5). 596–602. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.-G. Neumann Breakdown of academic impact, for papers by H. Peter Breakdown of academic impact, for papers by H.‐G. Neumann Breakdown of academic impact, for papers by F. Poncelet Breakdown of academic impact, for papers by Alan L. Mendrala Breakdown of academic impact, for papers by István Vincze Breakdown of academic impact, for papers by N. Fedtke Breakdown of academic impact, for papers by Karen Yeowell-O’Connell Breakdown of academic impact, for papers by J.F. Quast Breakdown of academic impact, for papers by Mei‐Sie Lee
Rankless by CCL
2026